Caplin Point Laboratories

Caplin Point share price hits record high after ANVISA clears Chennai plant

The facility was inspected between August 12 and 16, 2024, the company said.

Stocks to watch on Aug 19: Piramal Ent, Jubilant Pharmova, Urja Global

Stocks to watch on August 19: The promoters of the company have announced that on August 16, 2024, an entity within the Promoter Group acquired 616,615 equity shares of Piramal Enterprises

Caplin Point stock zooms over 5% on robust Q1 results; bottomline grows 20%

The surge in the stock price came after the company announced its June quarter of financial year 2025 (Q1FY25) results.

Caplin Point rallies 12%, hits 52-week high on strong Q1 results

With a healthy order book, company targets 40-50 per cent growth in revenues in FY24.

Caplin Point rises 10% after arm gets USFDA nod for anti-inflammatory drug

So far this calendar year (CY23), shares of Caplin Point have declined 0.4 per cent, as against 1 per cent rise in the S&P BSE Sensex

Caplin Point jumps 19%, hits record high; stock soars 37% in seven days

A combined 5.8 million equity shares, representing 7.6 per cent of the total equity of Caplin Point Laboratories, had changed hands on NSE and BSE till 12:56 pm

Stocks to watch: TechM, ACC, Nestle India, 5paisa, Caplin Point, ICICI Pru

Ace investor Ashish Kacholia increased stake in Caplin Point from 1.08 per cent as of December 2020 to 1.16 per cent as of March 2021

Caplin Point up 20% on USFDA approval for Verapamil Hydrochloride injection

Verapamil Hydrochloride is a calcium channel blocker used in the treatment of cardiac conditions such as high blood pressure, arrhythmias and angina.

Bajaj Finance, Symphony: 10 stocks that have zoomed over 5,000% in 10 years

As many as 63 stocks have zoomed over 1,000 per cent during this period

Caplin Labs gets USFDA nod for injection to prevent excessive blood loss

Caplin Steriles said it has developed and filed 11 ANDAs on its own and with partners, with 5 approvals so far

Caplin's sterile injectable site in Chennai gets two USFDA observations

Caplin Point Laboratories said it believes these observations are procedural in nature and corrective

Caplin Point Lab hits 11-week high; stock surges 14%

The stock rallied 14% to Rs 430, trading at its highest level since November 16, 2018 on the BSE.

Caplin Point falls 11% on disappointing Q4 results

The stock fell 11% to Rs 532 on the BSE in intra-day trade after the company's ebitda margin in March quarter declined by 400bps to 35% from 39% in previous year quarter.

Caplin Point Labs zooms over 40% in six days on strong Q4 results

The stock hit a new high of Rs 5784, rallied 41% in past six trading sessions from Rs 406 on May 10

Caplin Point Lab surges 15% on strong Q4 results

The stock hit a 52-week high of Rs 467 after the company posted 114% growth in profit at Rs 33 cr

Caplin Point Lab zooms over 40% in three days post stock split

The stock hit a record high of Rs 414, rallied 42% in past three trading sessions from Rs 291 on October 18, 2016.